Cleared Traditional

K120661 - THE T.A.L.O.N. INTRAOSSOUS INFUSION SYSTEM BY VIDACRE

K120661 is an FDA 510(k) clearance for THE T.A.L.O.N. INTRAOSSOUS INFUSION SYS..., manufactured by Vidacare Corporation. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K120661 · Vidacare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
90d
Days
Class 2
Risk

K120661 is an FDA 510(k) clearance for the THE T.A.L.O.N. INTRAOSSOUS INFUSION SYSTEM BY VIDACRE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Vidacare Corporation (Irvine, US). The FDA issued a Cleared decision on June 3, 2012 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Vidacare Corporation devices

FDA 510(k) Submission Details - K120661

510(k) Number K120661 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2012
Decision Date June 03, 2012
Days to Decision 90 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 129d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 500
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K120661.
COMFORT EZ
K121632 · Simple Diagnostics, Inc. · Aug 2012
SAFETY INFUSION SET
K121908 · Greiner Bio-One North America, Inc. · Jul 2012
INSULIN PEN NEEDLE
K120690 · Tiger Medical Products, Ltd. · Jun 2012
PUSH-ON NEEDLE 30GX8MM
K120191 · Scandinavian Health Limited · May 2012
STERILE INSULIN PEN NEEDLE
K113186 · Shina Corp. · Apr 2012
TERUMO SURGUARD 3 SAFETY NEEDLE TERUMO SURGUARD 3 HYPODERMIC SYRINGE WITH SAFETY NEEDLE
K113422 · Terumo (Philippines) Corporation · Mar 2012